Market Overview:
The global intercellular adhesion molecule 1 market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in the field of diagnostics and therapeutics. Based on type, the global intercellular adhesion molecule 1 market is segmented into DNP-003, CMS-024, MS-553, and others. The DNP-003 segment is expected to account for the largest share of the global intercellular adhesion molecule 1 market in 2018. This segment is also projected to grow at a CAGR of 7.8% from 2018 to 2030 owing to its high adoption rate across various applications such as dermatology, genito urinary system and sex hormones, Crohn's disease (CD), and others. Based on application, the global intercellular adhesion molecule 1 market is divided into dermatology, genito urinary system.
Product Definition:
Intercellular adhesion molecule 1 (ICAM-1) is a protein that helps cells stick to each other. It is important for normal cell function and is involved in many diseases, including cancer.
DNP-003:
DNP-003 is a new intercellular adhesion molecule 1 (ICAM-1) therapeutic monoclonal antibody that targets the CD18 subfamily of immunoglobulin superfamily. DNP-003 has shown potent in vitro and in vivo activity against multiple myeloma, B cell acute lymphoblastic leukemia, and malignant gliomas.
The global ICAM-1 market was valued at USD 648 million in 2016.
CMS-024:
CMS-024 is an intercellular adhesion molecule 1. It is also known as ICAM-1, CLAWR or CD24. Intercellular adhesion molecule 1 (ICAM-1) plays a major role in the immune response and inflammation by binding to its ligand, CCL22 (also known as Leukotriene B4).
Application Insights:
The use of intercellular adhesion molecules for the treatment of dermatology disorders accounted for the largest revenue share in 2017. The increasing prevalence of chronic diseases, such as diabetes and cancer, is expected to boost the demand for innovative drugs. Moreover, a rise in cosmetic surgeries is also anticipated to contribute toward market growth during the forecast period.
Dermatology was followed by genito urinary system and sex hormones as most common uses among other applications are gastrointestinal conditions and rheumatoid arthritis that involves joint inflammation along with osteoarthritis that involves pain & stiffness in joints.
Regional Analysis:
North America dominated the global intercellular adhesion molecule 1 market in 2017. The region is expected to maintain its position during the forecast period owing to high R&D investments and clinical trials of IEM1-targeted drugs. In addition, increasing cases of chronic diseases are also driving the regional market growth. For instance, according to statistics published by National Institute of Health (NIH), in 2015 around 18 million people were diagnosed with cancer each year in U.S., out of which 60% were estimated to die within a year due to their disease or condition.
Asia Pacific is anticipated to be one of the fastest growing regions over the forecast period owing rising awareness about early diagnosis.
Growth Factors:
- Increasing prevalence of chronic diseases: The increasing prevalence of chronic diseases is one of the key growth drivers for the Intercellular Adhesion Molecule 1 market. According to the World Health Organization, around 36 million people died due to chronic diseases in 2012, and this number is expected to reach 58 million by 2030. This will create a high demand for Intercellular Adhesion Molecule 1 products and services in the coming years.
- Growing geriatric population: The global geriatric population is growing at a rapid pace and this is creating a high demand for Intercellular Adhesion Molecule 1 products and services. By 2020, around 20% of the world’s population will be aged 65 or above, which will increase the need for interventions that can improve their health outcomes.
- Rising awareness about immunology: There has been an increasing awareness about immunology among healthcare professionals as well as patients in recent years. This has led to an increased demand for Intercellular Adhesion Molecule 1 products and services worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Intercellular Adhesion Molecule 1 Market Research Report
By Type
DNP-003, CMS-024, MS-553, Others
By Application
Dermatology, Genito Urinary System and Sex Hormones, Crohn's Disease, Others
By Companies
Atlantic Healthcare Plc, China Medical System Holdings Ltd, RXi Pharmaceuticals Corp
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
226
Number of Tables & Figures
159
Customization Available
Yes, the report can be customized as per your need.
Global Intercellular Adhesion Molecule 1 Market Report Segments:
The global Intercellular Adhesion Molecule 1 market is segmented on the basis of:
Types
DNP-003, CMS-024, MS-553, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dermatology, Genito Urinary System and Sex Hormones, Crohn's Disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Atlantic Healthcare Plc
- China Medical System Holdings Ltd
- RXi Pharmaceuticals Corp
Highlights of The Intercellular Adhesion Molecule 1 Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNP-003
- CMS-024
- MS-553
- Others
- By Application:
- Dermatology
- Genito Urinary System and Sex Hormones
- Crohn's Disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intercellular Adhesion Molecule 1 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intercellular adhesion molecule 1 (ICAM-1) is a protein that helps cells stick to each other. It is found on the surface of cells and helps them to communicate with each other. ICAM-1 can help cells to move around and interact with their surroundings.
Some of the key players operating in the intercellular adhesion molecule 1 market are Atlantic Healthcare Plc, China Medical System Holdings Ltd, RXi Pharmaceuticals Corp.
The intercellular adhesion molecule 1 market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intercellular Adhesion Molecule 1 Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intercellular Adhesion Molecule 1 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intercellular Adhesion Molecule 1 Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intercellular Adhesion Molecule 1 Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intercellular Adhesion Molecule 1 Market Size & Forecast, 2020-2028
4.5.1 Intercellular Adhesion Molecule 1 Market Size and Y-o-Y Growth
4.5.2 Intercellular Adhesion Molecule 1 Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 DNP-003
5.2.2 CMS-024
5.2.3 MS-553
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Dermatology
6.2.2 Genito Urinary System and Sex Hormones
6.2.3 Crohn's Disease
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intercellular Adhesion Molecule 1 Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intercellular Adhesion Molecule 1 Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 DNP-003
9.6.2 CMS-024
9.6.3 MS-553
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Dermatology
9.10.2 Genito Urinary System and Sex Hormones
9.10.3 Crohn's Disease
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 DNP-003
10.6.2 CMS-024
10.6.3 MS-553
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Dermatology
10.10.2 Genito Urinary System and Sex Hormones
10.10.3 Crohn's Disease
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 DNP-003
11.6.2 CMS-024
11.6.3 MS-553
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Dermatology
11.10.2 Genito Urinary System and Sex Hormones
11.10.3 Crohn's Disease
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 DNP-003
12.6.2 CMS-024
12.6.3 MS-553
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Dermatology
12.10.2 Genito Urinary System and Sex Hormones
12.10.3 Crohn's Disease
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 DNP-003
13.6.2 CMS-024
13.6.3 MS-553
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Dermatology
13.10.2 Genito Urinary System and Sex Hormones
13.10.3 Crohn's Disease
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intercellular Adhesion Molecule 1 Market: Competitive Dashboard
14.2 Global Intercellular Adhesion Molecule 1 Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Atlantic Healthcare Plc
14.3.2 China Medical System Holdings Ltd
14.3.3 RXi Pharmaceuticals Corp
